Loading cancer entity…
Loading cancer entity…
Clinical trials
6,746 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,045)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01576796 | Radiotherapy Dose Complement in the Treatment of Hypoxic Lesions Patients With Stage III Non-small-cell Lung Cancer(RTEP-5) | unknown | Phase 2 | 75 | Centre Henri BecquerelOTHER | 1 | Jul 28, 2016 | clinicaltrials |
| NCT02841228 | Intensity-modulated Radiotherapy (IMRT) With Simultaneous Integrated Boost (SIB) for Inoperable Non-small-cell Lung Cancer | unknown | Phase 2 | 40 | Hunan Province Tumor HospitalOTHER | 1 | Jul 22, 2016 |
| clinicaltrials |
| NCT00697333 | Radiotherapy Planning Based on Positron Emission Tomography With Fluoro-deoxyglucose For Advanced NSCLC(PET-Plan) | unknown | Phase 2 | 200 | Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie der DEGRO und DGNOTHER | 1 | Jul 14, 2016 | clinicaltrials |
| NCT02820116 | The Role of Icotinib in the Perioperative Treatment of IIIA - IIIB NSCLC Patients With EGFR Mutation | unknown | Phase 2 | 67 | Beijing Haidian HospitalOTHER | 1 | Jun 30, 2016 | clinicaltrials |
| NCT01803503 | Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors | unknown | Phase 2 | 80 | National University Hospital, SingaporeOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT02788058 | A Study of Hypofractionated Radiotherapy for Limited Metastatic NSCLC Harboring Sensitizing EGFR Mutations After First Line TKI Therapy | unknown | Phase 2 | 76 | First People's Hospital of HangzhouOTHER | 0 | Jun 2, 2016 | clinicaltrials |
| NCT02651441 | D-CIK Combined With Chemotherapy for Non-Small Cell Lung Cancer(NSCLC) | unknown | Phase 1 / Phase 2 | 60 | Shenzhen Hornetcorn Bio-technology Company, LTDINDUSTRY | 1 | May 24, 2016 | clinicaltrials |
| NCT02780778 | Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | 20 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 23, 2016 | clinicaltrials |
| NCT02766348 | Clinical Efficacy and Safety of Dendritic Cytotoxic Lymphocyte(DC-CTL) Cell Infusion in NSCLC Patients | unknown | Phase 2 | 60 | Shenzhen Hornetcorn Bio-technology Company, LTDINDUSTRY | 1 | May 9, 2016 | clinicaltrials |
| NCT02738983 | RT Plus EGFR-TKI for Wild-type NSCLC | unknown | Phase 2 | 22 | Hangzhou Cancer HospitalOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT02733107 | The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer | unknown | Phase 2 | 25 | Third Military Medical UniversityOTHER | 1 | Apr 12, 2016 | clinicaltrials |
| NCT00690963 | Individual Boosting in Non-Small Cell Lung Cancer Using Hypofractionation, Intensity-modulated Radiation Therapy and Respiratory Gating | unknown | Phase 1 / Phase 2 | 12 | AHS Cancer Control AlbertaOTHER | 1 | Apr 6, 2016 | clinicaltrials |
| NCT02037997 | Safety and Effectiveness Study of Chemotherapy in Combination With Erlotinib,or Sequential Erlotinib for Treatment in Patients With NSCLC | unknown | Phase 2 | 80 | Fudan UniversityOTHER | 1 | Feb 23, 2016 | clinicaltrials |
| NCT02669719 | Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLC | unknown | Phase 2 | 70 | Shanghai Chest HospitalOTHER | 1 | Feb 1, 2016 | clinicaltrials |
| NCT02650544 | Efficacy and Safety Analyses of Mirtazapine in NSCLC Patients With Depression | unknown | Phase 2 | 236 | Sun Yat-sen UniversityOTHER | 1 | Jan 8, 2016 | clinicaltrials |
| NCT00973310 | Erlotinib Concurrent With Radiation Therapy in Non-small-cell Lung Cancer | unknown | Phase 2 | 50 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 22, 2015 | clinicaltrials |
| NCT01660399 | Clinical Trial of Boanmycin Hydrochloride With Docetaxel for Patients With Lung Squamous Cell Cancer as Chemotherapy | unknown | Phase 2 | 300 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 22, 2015 | clinicaltrials |
| NCT02631460 | S1 vs.Pemetrexed Plus Carboplatin in Patients With EGFR Wild Type Stage IIIB or IV Nonsquamous NSCLC | unknown | Phase 2 | 470 | Sun Yat-sen UniversityOTHER | 1 | Dec 16, 2015 | clinicaltrials |
| NCT01494415 | Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer | unknown | Phase 2 | 21 | First People's Hospital of HangzhouOTHER | 1 | Dec 15, 2015 | clinicaltrials |
| NCT02584699 | Study of Stereotactic Ablative Radiotherapy (SABR) in Elderly Stage I NSCLC | unknown | Phase 2 | 40 | Luhua WangUNKNOWN | 1 | Oct 23, 2015 | clinicaltrials |
| NCT01707329 | Icotinib in Combination With Chemotherapy Versus Chemotherapy Alone in Patients Progressed After Icotinib Treatment | unknown | Phase 2 | 180 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Sep 9, 2015 | clinicaltrials |
| NCT02540824 | Study of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung Cancer | unknown | Phase 2 | 40 | Tongji UniversityOTHER | 1 | Sep 4, 2015 | clinicaltrials |
| NCT02535507 | Efficacy and Safety of Pyrotinib in Patients With HER2 Mutation Advanced Non-Small Cell Lung Cancer | unknown | Phase 2 | 40 | Tongji UniversityOTHER | 1 | Aug 28, 2015 | clinicaltrials |
| NCT01592617 | Phase II Study of S-488410 to Treat Non-small Cell Lung Cancer | unknown | Phase 2 | 45 | Shiga UniversityOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT01843647 | Neoadjuvant Therapy of Icotinib in Epidermal Growth Factor Receptor Mutated NSCLC Patients | unknown | Phase 2 | 100 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 15, 2015 | clinicaltrials |
| NCT02062515 | Icotinib in Advanced Non-small Cell Lung Cancer (NSCLC) With Hepatic Insufficiency | unknown | Phase 2 | 30 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 15, 2015 | clinicaltrials |
| NCT02006043 | Evaluate Erlotinib Efficacy and Safety as the 2nd/3rd Treatment in NSCLC With EGFR M(-) and C-met(-) | unknown | Phase 2 | 54 | Li ZhangOTHER | 1 | Jul 3, 2015 | clinicaltrials |
| NCT01172925 | Study of a Tiotropium Inhaler For Shortness of Breath in Advanced Non-Small Cell Lung Cancer(TIDAL) | unknown | Phase 2 | 34 | Hamilton Health Sciences CorporationOTHER | 1 | May 27, 2015 | clinicaltrials |
| NCT01929200 | Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR Mutation | unknown | Phase 2 | 120 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | May 22, 2015 | clinicaltrials |
| NCT02027090 | High Dose Versus Routine Dose Icotinib in Advanced Non-small Cell Lung Cancer Patients With Stable Disease | unknown | Phase 2 | 64 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | May 22, 2015 | clinicaltrials |
| NCT02430974 | Chemotherapy of NSCLC With or Without Icotinib | unknown | Phase 2 | 50 | Nanfang Hospital, Southern Medical UniversityOTHER | 0 | Apr 30, 2015 | clinicaltrials |
| NCT02407600 | Study Assessing Fosaprepitant in Advanced NSCLC Patients Treated With Carboplatin Based Chemotherapy | unknown | Phase 2 | 150 | Ajeet GajraOTHER | 1 | Apr 3, 2015 | clinicaltrials |
| NCT02407366 | Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer | unknown | Phase 2 | 80 | People's Hospital of Guangxi Zhuang Autonomous RegionOTHER | 1 | Apr 2, 2015 | clinicaltrials |
| NCT01549093 | Endostar Continued Pumping Into Vein Combining With Gemcitabine-Carboplatin to Treat Non-Small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | 90 | Hunan Province Tumor HospitalOTHER | 1 | Mar 24, 2015 | clinicaltrials |
| NCT02387086 | Gefitinib Combined With Thalidomide to Treat NSCLC | unknown | Phase 2 / Phase 3 | 380 | Bai JunOTHER | 0 | Mar 12, 2015 | clinicaltrials |
| NCT02009605 | Icotinib in Previously Treated Non/Light-smoking Patients With Advanced Squamous Cell Lung Cancer | unknown | Phase 2 | 30 | Zhejiang UniversityOTHER | 1 | Mar 5, 2015 | clinicaltrials |
| NCT02338011 | Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases)(EGFR) | unknown | Phase 2 / Phase 3 | 210 | Shanghai Chest HospitalOTHER | 1 | Jan 26, 2015 | clinicaltrials |
| NCT01690390 | Dose Escalation of Icotinib in Advanced Non-small Cell Lung Carcinoma (NSCLC) Patients Evaluated as Stable Disease | unknown | Phase 2 | 180 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Dec 30, 2014 | clinicaltrials |
| NCT01763385 | Erlotinib With Concurrent Brain Radiotherapy and Secondary Brain Radiotherapy After Recurrence With Erlotinib in NSCLC Non-increased-intracranial-pressure Symptomatic Brain Metastases(TRACTS) | unknown | Phase 2 | 210 | Wu Jieping Medical FoundationOTHER | 1 | Dec 23, 2014 | clinicaltrials |
| NCT02319577 | GEfitinib Plus viNOrelbine in Advanced EGFR Mutated NSCLC. GENOA Trial | unknown | Phase 2 | 80 | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, ItalyOTHER | 1 | Dec 18, 2014 | clinicaltrials |
| NCT01784549 | Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA (N2)Disease(CONTEST) | unknown | Phase 2 | 168 | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, ItalyOTHER | 1 | Nov 25, 2014 | clinicaltrials |
| NCT02272127 | Study of Chemotherapy Plus Icotinib to Treat EGFR Mutation-positive Non-small-cell Lung Cancer | unknown | Phase 2 | 100 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Oct 22, 2014 | clinicaltrials |
| NCT01424709 | Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC)(BRAVO) | unknown | Phase 2 | 120 | Tongji UniversityOTHER | 1 | Sep 25, 2014 | clinicaltrials |
| NCT02224547 | Risk-adapted Stereotactic Body Radiotherapy for Early Non-Small Cell Lung Cancer Using the VERO Stereotactic Body Radio Therapy System | unknown | Phase 2 | 58 | Universitair Ziekenhuis BrusselOTHER | 1 | Sep 9, 2014 | clinicaltrials |
| NCT02215356 | Icotinib With Concurrent Radiotherapy Versus Chemotherapy With Concurrent Radiotherapy in Non-small Cell Lung Cancer | unknown | Phase 2 | 120 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Aug 13, 2014 | clinicaltrials |
| NCT02191059 | Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung Cancer | unknown | Phase 2 | 60 | Shandong Cancer Hospital and InstituteOTHER | 1 | Jul 31, 2014 | clinicaltrials |
| NCT02146118 | A Phase II Study to Assess Efficacy of Combined Treatment With Erlotinib (Tarceva) and Silybin-phytosome (Siliphos) in Patients With EGFR Mutant Lung Adenocarcinoma | unknown | Phase 2 | 42 | MedicalLogicINDUSTRY | 1 | May 23, 2014 | clinicaltrials |
| NCT01969955 | Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer | unknown | Phase 2 | 50 | Chinese Academy of Medical SciencesOTHER | 1 | Apr 25, 2014 | clinicaltrials |
| NCT01861223 | Afatinib Plus Nimotuzumb for NSCLC | unknown | Phase 1 / Phase 2 | 50 | Samsung Medical CenterOTHER | 1 | Feb 25, 2014 | clinicaltrials |
| NCT02036359 | Erlotinib Monotherapy Versus Docetaxel and Cisplatin as Neoadjuvant Therapy in Patients of stageIIIA Lung ca(Oncology) | unknown | Phase 2 | 76 | National Taiwan University HospitalOTHER | 1 | Jan 15, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Jul 28, 2016source: clinicaltrials